| Date Filed | Type | Description |
| 02/28/2018 |
4
| VENROCK HEALTHCARE CAPITAL PARTNERS LP (10% Owner) has filed a Form 4 on ARCA biopharma, Inc.|
Txns:
| Sold 1,500,000 shares
@ $0.55, valued at
$825k
Sold 41,331 shares
@ $0.53, valued at
$21.9k
|
|
| 02/13/2017 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings: |
| 11/14/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/12/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 05/13/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/12/2016 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/13/2015 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/13/2015 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 05/14/2015 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/13/2015 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/13/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/13/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/07/2014 |
4
| Venrock Associates VI, L.P. (10% Owner) has filed a Form 4 on Avalanche Biotechnologies, Inc.|
Txns:
| Converted 1,965,471 shares
@ $0
Bought 400,000 shares
@ $17, valued at
$6.8M
Converted 1,965,471 preferred shares
@ $0 |
|
| 05/14/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/13/2014 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/19/2013 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals, Inc.|
Txns:
| Sold 150,000 shares
@ $14.06, valued at
$2.1M
|
|
| 11/15/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 05/14/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 03/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/13/2013 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/13/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 09/24/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 19,273 shares
@ $6.3019, valued at
$121.5k
|
|
| 09/13/2012 |
4
| VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Anacor Pharmaceuticals Inc|
Txns:
| Sold 10,177 shares
@ $6.6427, valued at
$67.6k
Sold 15,000 shares
@ $6.5553, valued at
$98.3k
|
|
| 08/13/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 07/05/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/11/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/13/2012 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 11/10/2011 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 08/11/2011 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 05/12/2011 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/14/2011 |
13F-HR
| Form 13F-HR - Quarterly report filed by institutional managers, Holdings |
| 02/04/2011 |
4
| VENROCK HEALTHCARE CAPITAL PARTNERS LP (10% Owner) has filed a Form 4 on Chelsea Therapeutics International, Ltd.|
Txns:
| Bought 75,000 shares
@ $4.9999, valued at
$375k
|
|
| 02/04/2011 |
3
| VENROCK HEALTHCARE CAPITAL PARTNERS LP (10% Owner) has filed a Form 3 on Chelsea Therapeutics International, Ltd. |
|